Understanding the mechanisms of reversal of type 2 diabetes.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing pathophysiological mechanisms and trial data without systematic review methodology.
PubMed 31097391 · doi:10.1016/S2213-8587(19)30076-2
What was done
This narrative review synthesizes clinical and pathophysiological studies examining how type 2 diabetes develops and how substantial weight loss can reverse the condition, referencing findings from the primary care-based Diabetes Remission Clinical Trial (DiRECT).
What was found
Excess fat accumulation in the liver worsens hepatic insulin responsiveness and increases glucose production, while fat accumulation in the pancreas causes beta-cell dysfunction. Substantial weight loss removes ectopic organ fat, normalizes hepatic insulin sensitivity, and allows recovery of acute insulin secretion in the early years after diagnosis. Cited results from the DiRECT trial showed diabetes remission rates of 46% at 12 months and 36% at 24 months mediated by weight loss.
Why it matters
This mechanistic framework establishes that type 2 diabetes is not necessarily a permanent, progressive disease, supporting clinical guidance aimed at achieving remission through targeted weight loss early after diagnosis.
Limits
The abstract describes a narrative review rather than an original trial or systematic review. Key details such as total sample size, participant demographics, confidence intervals, and long-term durability beyond 24 months are not reported in the abstract.
Cited by
- supports Ectopic fat accumulation within the pancreas reduces the amount of insulin secreted by pancreatic beta cells.